Dasatinib propylene glycol is a solvate form of dasatinib, a tyrosine kinase inhibitor used to treat certain types of leukemia (e.g., CML and ALL). The propylene glycol component improves solubility and stability, making it more suitable for pharmaceutical formulations. It is grouped under the following drug class(es): Antineoplastic agents and Kinase inhibitors. Its therapeutic use is listed as antineoplastics. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Dasatinib (S)-propylene glycol and Sprycel. Its PubChem CID is 155173048.
Dasatinib propylene glycol
| CAS No | 2059090-84-3 |
|---|---|
| Molecular Formula | C25H34ClN7O4S |
| Molecular Weight | 564.1 g/mol |
| Synonyms | N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;propane-1,2-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
, CML and ALL). The propylene glycol component improves solubility and stability, making it more suitable for pharmaceutical formulations. It is grouped under the following drug class(es): Antineoplastic agents and Kinase inhibitors.
The listed CAS number is 2059090-84-3.
The listed molecular formula is C25H34ClN7O4S.
The listed molecular weight is 564.1 g/mol.
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;propane-1,2-diol.
The source lists Dasatinib (S)-propylene glycol and Sprycel.